M2I Life Sciences
M2I Life Sciences is a privately held French industrial group and the self-declared European leader in pheromone-based biological plant protection for agriculture, serving 80 countries with crop protection products across 60 crops and a parallel Chemistry & Life Sciences line.
- Company typePrivate
- Founded-
- HeadquartersNot specified, France
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What M2I Life Sciences does
M2I Life Sciences, operating as the M2i Group, is a privately held French industrial company headquartered in Saint Cloud, France, founded in 2012. It is positioned as the European leader in biological plant protection using pheromone-based technologies, offering an alternative to conventional chemical pesticides for agricultural producers. The company serves agricultural customers across 80 countries, with products applied to 60 crops, and the platform reports avoiding an average of 20,000 tonnes of pesticides per year.
The company operates two core product lines. First, Biocontrol products are pheromone-based biological plant protection solutions designed for reasoned and organic agriculture, providing crop protection without residues while preserving biodiversity. Second, the Chemistry & Life Sciences line leverages organic chemistry expertise to develop and produce active ingredients and intermediates for broader applications. The proprietary technology rests on pheromone molecule design and production know-how, protected by 40 patent families, and the company controls the full value chain, from R&D laboratories to active ingredient production, formulation, field trials, and regulatory homologations.
M2i generates revenue through one-time sales of its biocontrol products and active ingredients/intermediates, with pricing not publicly disclosed. Its go-to-market is sales-led, combining direct engagement with agricultural producers and distributors for broader geographic reach across 80 countries. The company operates 4 production sites in France, employs approximately 160 people, and has received 45 awards, with no venture capital, private equity, or institutional ownership disclosed in the available material.
M2I Life Sciences firmographics
Firmographics- Name
- M2I Life Sciences
- Legal name
- M2i Group
- Website
- https://m2i-group.fr
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- M2I Life Sciences is a privately held French industrial group and the self-declared European leader in pheromone-based biological plant protection for agriculture, serving 80 countries with crop protection products across 60 crops and a parallel Chemistry & Life Sciences line.
- Ownership category
- akta.pro rank
Where M2I Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Not specified
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
M2I Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Biocontrol products: Sale of pheromone-based biological control products for agricultural use. These products protect crops without residues while preserving biodiversity.
- Active ingredients and intermediates: Development and production of active pharmaceutical/chemical ingredients and intermediates for various applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
M2I Life Sciences product offering
Product offeringCore offering
M2I Life Sciences is a French industrial group that designs, manufactures, and sells pheromone-based biocontrol products for biological plant protection as a substitute for conventional chemical pesticides across 60 crops. In addition, through its Chemistry & Life Sciences division, the company develops and produces active principles and intermediates using its expertise in solid organic chemistry. The group controls the entire value chain from R&D laboratory to production of active ingredients and formulations, and from field trials to regulatory homologations across 80 countries, operating 4 sites in France.
Product overview
M2I Life Sciences is a French industrial group that operates two core product lines: (1) Biocontrol products based on pheromones for biological plant protection in reasoned and organic agriculture, protecting 60+ crops without chemical residues; and (2) Chemistry & Life Sciences services for the development and production of active principles and intermediates. The company controls the entire value chain from R&D laboratory to active production and formulation, through field trials to regulatory approvals.
Differentiator
Problem solved
Functional benefit
Products and services
- Biocontrol Products (Pheromone-based) Biological plant protection products based on pheromones, designed for reasoned and organic agriculture, providing effective crop protection without residues while preserving biodiversity. These products serve agricultural producers and distributors across 60 crop varieties.
- Chemistry & Life Sciences (Active Ingredients and Intermediates) Development and production of active principles and intermediates based on solid organic chemistry expertise, serving life sciences, pharmaceutical, crop science, and specialty chemical customers with R&D, industrial performance, and field-to-commercialization capabilities.
Quantifiable outcome
- 20,000 tonnes of pesticides avoided per year
- +2 more outcomes
Companies that use M2I Life Sciences
Customer profileSegments1 record
Ideal customer profiles2 records
M2I Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
M2I Life Sciences partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights4 records
M2I Life Sciences competitors and assessment
Company assessmentDirect peers
- Suterra: US-based pioneer in pheromone-based pest control for specialty crops and tree fruit. The most direct technology peer to M2i, using the same mating disruption and monitoring modality, with overlapping customer use cases in pheromone-based biocontrol.
- Biobest Group: Belgian biocontrol specialist offering bumblebees, beneficial insects, mites, and biopesticides for protected and open-field crops. Closest European comparable to M2i as a continent-leading biocontrol player serving the same agricultural customer base with overlapping sustainable crop protection solutions.
- Koppert Biological Systems: Dutch biological crop protection leader offering beneficial insects, biostimulants, microbials, and pheromone-based products globally. Direct peer to M2i in European biocontrol with comparable product breadth and an established international distribution footprint.
- Trécé: US-based manufacturer of pheromone-based products and insect monitoring systems for agriculture. Direct technology peer to M2i, operating in the same pheromone disruption and trapping modality for specialty and row crops.
- Certis Biologicals: US-based biopesticides company with a portfolio of biological crop protection products including microbial, plant extract, and semiochemical solutions. Comparable to M2i as a focused biologicals player serving the same agricultural customer segment.
- Andermatt Group: Swiss family-owned biocontrol group producing pheromones, microbials, beneficial nematodes, and biostimulants. Direct European peer to M2i with similar product portfolio, family-owned private ownership structure, and multi-jurisdiction regulatory expertise.
Broad incumbents
- Bayer Crop Science: Global agrochemical and seed leader with a biological crop protection portfolio and stated ambition to grow the biologicals share of its revenue. Competes with M2i across the broader crop protection market rather than specializing in pheromones.
- Syngenta: Swiss-headquartered global agrochemical company with an expanding biologicals portfolio acquired and built through M&A and internal development. Competes with M2i in crop protection broadly and has signaled biologicals as a strategic growth area.
- BASF: German agrochemical giant with a growing biological crop protection portfolio alongside its core chemical pesticide business. Competes broadly with M2i in crop protection and has publicly committed to expanding its biologicals offering as part of its agricultural solutions strategy.
Emerging players
- Bioplanet: Italian producer of beneficial insects, mites, and biopesticides for protected and open-field crops. Smaller and more regional than M2i, but overlaps on the European biologicals category and serves a comparable grower customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
M2I Life Sciences social profiles
Digital presenceM2I Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
M2I Life Sciences leadership team
Management profileNumber of profiles
M2I Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M2I Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M2I Life Sciences
What does M2I Life Sciences do?
M2I Life Sciences is a French industrial group that designs, manufactures, and sells pheromone-based biocontrol products for biological plant protection as a substitute for conventional chemical pesticides across 60 crops. In addition, through its Chemistry & Life Sciences division, the company develops and produces active principles and intermediates using its expertise in solid organic chemistry. The group controls the entire value chain from R&D laboratory to production of active ingredients and formulations, and from field trials to regulatory homologations across 80 countries, operating 4 sites in France.
Is M2I Life Sciences a public or private company?
M2I Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was M2I Life Sciences founded?
M2I Life Sciences was founded in -1. It employs 101 to 250 people.
Where is M2I Life Sciences based?
M2I Life Sciences is headquartered in Not specified, France, in the Europe region.
How does M2I Life Sciences make money?
Two revenue lines are on record. Biocontrol products are the primary driver. The others are active ingredients and intermediates.
Who are M2I Life Sciences's main competitors?
Direct peers on record are Suterra, Biobest Group, Koppert Biological Systems, Trécé, Certis Biologicals and Andermatt Group. Broad incumbents are Bayer Crop Science, Syngenta and BASF. Bioplanet is listed as an emerging player.
Does M2I Life Sciences have an API?
No public API is recorded for M2I Life Sciences.